Correlation Between Taro Pharmaceutical and Pharmacyclics
Can any of the company-specific risk be diversified away by investing in both Taro Pharmaceutical and Pharmacyclics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taro Pharmaceutical and Pharmacyclics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Taro Pharmaceutical Industries and Pharmacyclics, you can compare the effects of market volatilities on Taro Pharmaceutical and Pharmacyclics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taro Pharmaceutical with a short position of Pharmacyclics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taro Pharmaceutical and Pharmacyclics.
Diversification Opportunities for Taro Pharmaceutical and Pharmacyclics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Taro and Pharmacyclics is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Taro Pharmaceutical Industries and Pharmacyclics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmacyclics and Taro Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taro Pharmaceutical Industries are associated (or correlated) with Pharmacyclics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmacyclics has no effect on the direction of Taro Pharmaceutical i.e., Taro Pharmaceutical and Pharmacyclics go up and down completely randomly.
Pair Corralation between Taro Pharmaceutical and Pharmacyclics
If you would invest (100.00) in Pharmacyclics on January 24, 2024 and sell it today you would earn a total of 100.00 from holding Pharmacyclics or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Taro Pharmaceutical Industries vs. Pharmacyclics
Performance |
| Timeline |
| Taro Pharmaceutical |
| Pharmacyclics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Taro Pharmaceutical and Pharmacyclics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Taro Pharmaceutical and Pharmacyclics
The main advantage of trading using opposite Taro Pharmaceutical and Pharmacyclics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taro Pharmaceutical position performs unexpectedly, Pharmacyclics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmacyclics will offset losses from the drop in Pharmacyclics' long position.| Taro Pharmaceutical vs. Silver Spike Investment | Taro Pharmaceutical vs. Alkermes Plc | Taro Pharmaceutical vs. Eagle Pharmaceuticals | Taro Pharmaceutical vs. Evotec SE ADR |
| Pharmacyclics vs. US Silica Holdings | Pharmacyclics vs. Uranium Energy Corp | Pharmacyclics vs. Bm Technologies | Pharmacyclics vs. Q2 Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |